{"transactions":[{"id":701311,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-07-30T00:06:00.000Z","date":"2026-07-29","kind":"sale","planned":false,"acquired":false,"shares":18217,"price":33.4652,"value":609635.5484,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to the performance restricted stock unit award described in Footnote 1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.28 to $33.805, inclusive. The Reporting Person  undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the this footnote."}],"balance_after":422760,"source":{"system":"sec-edgar","filing":"0001193125-26-324446","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526324446/ownership.xml","form_type":"4"}},{"id":701310,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-07-30T00:06:00.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":31667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2023, 33.33% of which vested on July 28, 2026 upon the achievement of a non-financial performance goal."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 120 shares acquired on May 20, 2026 pursuant to the Issuer's 2024 Employee Stock Purchase Plan."}],"balance_after":440977,"source":{"system":"sec-edgar","filing":"0001193125-26-324446","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526324446/ownership.xml","form_type":"4"}},{"id":950003,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T01:31:16.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":91000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"25% of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":91000,"derivative":{"exercise_price":35.42,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":91000},"source":{"system":"sec-edgar","filing":"0001193125-26-003115","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526003115/ownership.xml","form_type":"4"}},{"id":950002,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-01-06T01:31:16.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":1600,"price":35.0731,"value":56116.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain restricted stock unit awards that vested on January 3, 2026 and the performance restricted stock unit awards described in Footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $34.88 to $35.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":409190,"source":{"system":"sec-edgar","filing":"0001193125-26-003115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526003115/ownership.xml","form_type":"4"}},{"id":950001,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-01-06T01:31:16.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":10500,"price":34.2193,"value":359302.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain restricted stock unit awards that vested on January 3, 2026 and the performance restricted stock unit awards described in Footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $33.87 to $34.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":410790,"source":{"system":"sec-edgar","filing":"0001193125-26-003115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526003115/ownership.xml","form_type":"4"}},{"id":950000,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-01-06T01:31:16.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":13600,"price":33.3732,"value":453875.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain restricted stock unit awards that vested on January 3, 2026 and the performance restricted stock unit awards described in Footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $32.87 to $33.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":421290,"source":{"system":"sec-edgar","filing":"0001193125-26-003115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526003115/ownership.xml","form_type":"4"}},{"id":949999,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-01-06T01:31:16.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":31961,"price":32.2928,"value":1032110.1808,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain restricted stock unit awards that vested on January 3, 2026 and the performance restricted stock unit awards described in Footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $31.87 to $32.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":434890,"source":{"system":"sec-edgar","filing":"0001193125-26-003115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526003115/ownership.xml","form_type":"4"}},{"id":949998,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-01-06T01:31:16.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":32049,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2023, 33.33% of which vested on January 2, 2026, upon the achievement of a non-financial performance goal and a second performance restricted stock unit award that was granted on January 3, 2025, 1.665% of which vested on January 2, 2026, upon the partial achievement of a non-financial performance goal."}],"balance_after":466851,"source":{"system":"sec-edgar","filing":"0001193125-26-003115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526003115/ownership.xml","form_type":"4"}},{"id":949997,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-01-06T01:31:16.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award (\"RSU\") of common stock under the Issuer's 2024 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 11,111 shares acquired on May 20, 2024 pursuant to the Issuer's 2014 Employee Stock Purchase Plan and 108 shares acquired on May 20, 2025 and 116 shares acquired on November 20, 2025 both pursuant to the Issuer's 2024 Employee Stock Purchase Plan."}],"balance_after":434802,"source":{"system":"sec-edgar","filing":"0001193125-26-003115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526003115/ownership.xml","form_type":"4"}},{"id":1012434,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2025-10-28T23:51:22.000Z","date":"2025-10-28","kind":"sale","planned":false,"acquired":false,"shares":6185,"price":35.0027,"value":216491.6995,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to the performance restricted stock unit award described in Footnote 1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.69 to $35.40, inclusive. The Reporting Person  undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the this footnote."}],"balance_after":382467,"source":{"system":"sec-edgar","filing":"0001193125-25-254304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312525254304/ownership.xml","form_type":"4"}},{"id":1012433,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2025-10-28T23:51:22.000Z","date":"2025-10-27","kind":"grant","planned":false,"acquired":true,"shares":11117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2025, 33.33% of which vested on October 27, 2025 upon the achievement of a non-financial performance goal and 15% of which vested also on October 27, 2025 upon the partial achievement of a non-financial performance goal."}],"balance_after":388652,"source":{"system":"sec-edgar","filing":"0001193125-25-254304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312525254304/ownership.xml","form_type":"4"}},{"id":1091831,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2025-07-03T19:30:32.000Z","date":"2025-07-03","kind":"sale","planned":false,"acquired":false,"shares":4266,"price":27.7714,"value":118472.7924,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to the performance restricted stock unit award described in Footnote 1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.755 to $27.79, inclusive. The Reporting Person  undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the this footnote."}],"balance_after":377535,"source":{"system":"sec-edgar","filing":"0000950170-25-093791","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017025093791/ownership.xml","form_type":"4"}},{"id":1091830,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2025-07-03T19:30:32.000Z","date":"2025-07-02","kind":"grant","planned":false,"acquired":true,"shares":7667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2025, 33.33% of which vested on July 2, 2025 upon the achievement of a non-financial performance goal."}],"balance_after":381801,"source":{"system":"sec-edgar","filing":"0000950170-25-093791","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017025093791/ownership.xml","form_type":"4"}},{"id":1309708,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T01:15:41.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":37200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":37200,"derivative":{"exercise_price":42.89,"exercise_date":"2026-01-03","expiration_date":"2035-01-03","underlying":"Common Stock","underlying_shares":37200},"source":{"system":"sec-edgar","filing":"0000950170-25-002486","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017025002486/ownership.xml","form_type":"4"}},{"id":1309707,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2025-01-07T01:15:41.000Z","date":"2025-01-06","kind":"sale","planned":false,"acquired":false,"shares":5100,"price":43.3165,"value":220914.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain restricted stock unit awards and certain performance restricted stock unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.20 to $43.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":374134,"source":{"system":"sec-edgar","filing":"0000950170-25-002486","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017025002486/ownership.xml","form_type":"4"}},{"id":1309706,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2025-01-07T01:15:41.000Z","date":"2025-01-06","kind":"sale","planned":false,"acquired":false,"shares":49115,"price":42.6893,"value":2096684.9695,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain restricted stock unit awards and certain performance restricted stock unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.20 to $43.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":379234,"source":{"system":"sec-edgar","filing":"0000950170-25-002486","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017025002486/ownership.xml","form_type":"4"}},{"id":1309705,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2025-01-07T01:15:41.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":21667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2024, 33.33% of which vested on January 3, 2025 upon the achievement of a non-financial performance goal."}],"balance_after":428349,"source":{"system":"sec-edgar","filing":"0000950170-25-002486","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017025002486/ownership.xml","form_type":"4"}},{"id":1309704,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2025-01-07T01:15:41.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":44533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award (\"RSU\") of common stock under the Issuer's 2024 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award."}],"balance_after":406682,"source":{"system":"sec-edgar","filing":"0000950170-25-002486","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017025002486/ownership.xml","form_type":"4"}},{"id":1445100,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-07-31T20:05:07.000Z","date":"2024-07-30","kind":"sale","planned":false,"acquired":false,"shares":3322,"price":57.82,"value":192078.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.51 to $58.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":362149,"source":{"system":"sec-edgar","filing":"0000950170-24-088537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024088537/ownership.xml","form_type":"4"}},{"id":1445099,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-07-31T20:05:07.000Z","date":"2024-07-30","kind":"sale","planned":false,"acquired":false,"shares":14704,"price":56.98,"value":837833.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.48 to $57.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":365471,"source":{"system":"sec-edgar","filing":"0000950170-24-088537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024088537/ownership.xml","form_type":"4"}},{"id":1445098,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-07-31T20:05:07.000Z","date":"2024-07-29","kind":"grant","planned":false,"acquired":true,"shares":21667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2024, 33.33% of which vested on July 29, 2024 upon the achievement of a non-financial performance goal."}],"balance_after":380175,"source":{"system":"sec-edgar","filing":"0000950170-24-088537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024088537/ownership.xml","form_type":"4"}},{"id":1445097,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-07-31T20:05:07.000Z","date":"2024-07-29","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 4, 2021, 33.33% of which vested on July 29, 2024 upon the achievement of a non-financial performance goal."}],"balance_after":358508,"source":{"system":"sec-edgar","filing":"0000950170-24-088537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024088537/ownership.xml","form_type":"4"}},{"id":1530256,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-03T01:27:45.000Z","date":"2024-05-01","kind":"exercise","planned":true,"acquired":false,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date."}],"balance_after":153000,"derivative":{"exercise_price":8.52,"exercise_date":"2024-01-03","expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001209191-24-005486","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005486/doc4.xml","form_type":"4"}},{"id":1530255,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-03T01:27:45.000Z","date":"2024-05-01","kind":"exercise","planned":true,"acquired":false,"shares":35426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date."}],"balance_after":18574,"derivative":{"exercise_price":7.77,"exercise_date":"2021-01-03","expiration_date":"2030-01-03","underlying":"Common Stock","underlying_shares":35426},"source":{"system":"sec-edgar","filing":"0001209191-24-005486","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005486/doc4.xml","form_type":"4"}},{"id":1530254,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-03T01:27:45.000Z","date":"2024-05-01","kind":"exercise","planned":true,"acquired":false,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"One-third of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":5.8,"exercise_date":"2022-01-04","expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-24-005486","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005486/doc4.xml","form_type":"4"}},{"id":1530253,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-03T01:27:45.000Z","date":"2024-05-01","kind":"exercise","planned":true,"acquired":false,"shares":87000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date."}],"balance_after":87000,"derivative":{"exercise_price":4.88,"exercise_date":"2023-01-03","expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":87000},"source":{"system":"sec-edgar","filing":"0001209191-24-005486","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005486/doc4.xml","form_type":"4"}},{"id":1530252,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-03T01:27:45.000Z","date":"2024-05-01","kind":"exercise","planned":true,"acquired":false,"shares":17999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date."}],"balance_after":1,"derivative":{"exercise_price":4.68,"exercise_date":"2021-03-31","expiration_date":"2030-03-31","underlying":"Common Stock","underlying_shares":17999},"source":{"system":"sec-edgar","filing":"0001209191-24-005486","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005486/doc4.xml","form_type":"4"}},{"id":1530251,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-05-03T01:27:45.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":6248,"price":80.0753,"value":500310.4744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $80.02 to $80.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":348508,"source":{"system":"sec-edgar","filing":"0001209191-24-005486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005486/doc4.xml","form_type":"4"}},{"id":1530250,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-05-03T01:27:45.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":119946,"price":79.2945,"value":9511058.097,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $79.00 to $79.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":354756,"source":{"system":"sec-edgar","filing":"0001209191-24-005486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005486/doc4.xml","form_type":"4"}},{"id":1530249,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-05-03T01:27:45.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":105343,"price":78.6476,"value":8284974.1268,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $78.00 to $78.9983, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":474702,"source":{"system":"sec-edgar","filing":"0001209191-24-005486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005486/doc4.xml","form_type":"4"}},{"id":1530248,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-05-03T01:27:45.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":26142,"price":77.4933,"value":2025829.8486,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $77.00 to $77.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":580045,"source":{"system":"sec-edgar","filing":"0001209191-24-005486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005486/doc4.xml","form_type":"4"}},{"id":1530247,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-05-03T01:27:45.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":23746,"price":76.4045,"value":1814301.257,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $76.09 to $76.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":606187,"source":{"system":"sec-edgar","filing":"0001209191-24-005486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005486/doc4.xml","form_type":"4"}},{"id":1530246,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-05-03T01:27:45.000Z","date":"2024-05-01","kind":"exercise","planned":true,"acquired":true,"shares":51000,"price":8.52,"value":434520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2024."}],"balance_after":629933,"source":{"system":"sec-edgar","filing":"0001209191-24-005486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005486/doc4.xml","form_type":"4"}},{"id":1530245,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-05-03T01:27:45.000Z","date":"2024-05-01","kind":"exercise","planned":true,"acquired":true,"shares":35426,"price":7.77,"value":275260.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2024."}],"balance_after":578933,"source":{"system":"sec-edgar","filing":"0001209191-24-005486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005486/doc4.xml","form_type":"4"}},{"id":1530244,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-05-03T01:27:45.000Z","date":"2024-05-01","kind":"exercise","planned":true,"acquired":true,"shares":90000,"price":5.8,"value":522000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2024."}],"balance_after":543507,"source":{"system":"sec-edgar","filing":"0001209191-24-005486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005486/doc4.xml","form_type":"4"}},{"id":1530243,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-05-03T01:27:45.000Z","date":"2024-05-01","kind":"exercise","planned":true,"acquired":true,"shares":87000,"price":4.88,"value":424560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2024."}],"balance_after":453507,"source":{"system":"sec-edgar","filing":"0001209191-24-005486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005486/doc4.xml","form_type":"4"}},{"id":1530242,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-05-03T01:27:45.000Z","date":"2024-05-01","kind":"exercise","planned":true,"acquired":true,"shares":17999,"price":4.68,"value":84235.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2024."}],"balance_after":366507,"source":{"system":"sec-edgar","filing":"0001209191-24-005486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005486/doc4.xml","form_type":"4"}},{"id":1559219,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-03-28T00:52:15.000Z","date":"2024-03-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":16610,"price":83.34,"value":1384277.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon\nthe vesting of certain shares of common stock subject to certain performance restricted stock units."}],"balance_after":363565,"source":{"system":"sec-edgar","filing":"0001209191-24-005118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005118/doc4.xml","form_type":"4"}},{"id":1559218,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-03-28T00:52:15.000Z","date":"2024-03-27","kind":"grant","planned":false,"acquired":true,"shares":31667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2023, 33.33% of which vested on March 27, 2024 upon the achievement of a non-financial performance goal."}],"balance_after":380175,"source":{"system":"sec-edgar","filing":"0001209191-24-005118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005118/doc4.xml","form_type":"4"}},{"id":1602353,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-03-05T00:52:22.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":16958,"price":85.22,"value":1445160.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon\nthe vesting of certain shares of common stock subject to certain performance restricted stock units."}],"balance_after":348508,"source":{"system":"sec-edgar","filing":"0001209191-24-004232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124004232/doc4.xml","form_type":"4"}},{"id":1602352,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-03-05T00:52:22.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":31667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2023, 33.33% of which vested on March 1, 2024 upon the achievement of a non-financial performance goal."}],"balance_after":365466,"source":{"system":"sec-edgar","filing":"0001209191-24-004232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124004232/doc4.xml","form_type":"4"}},{"id":1686953,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-05T02:36:41.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":155000,"derivative":{"exercise_price":17.4,"exercise_date":"2025-01-03","expiration_date":"2034-01-03","underlying":"Common Stock","underlying_shares":155000},"source":{"system":"sec-edgar","filing":"0001209191-24-000930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124000930/doc4.xml","form_type":"4"}},{"id":1686952,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-01-05T02:36:41.000Z","date":"2024-01-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":14199,"price":18.58,"value":263817.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units."}],"balance_after":333799,"source":{"system":"sec-edgar","filing":"0001209191-24-000930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124000930/doc4.xml","form_type":"4"}},{"id":1686951,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-01-05T02:36:41.000Z","date":"2024-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":32677,"price":17.4,"value":568579.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units."}],"balance_after":347998,"source":{"system":"sec-edgar","filing":"0001209191-24-000930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124000930/doc4.xml","form_type":"4"}},{"id":1686950,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-01-05T02:36:41.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents a restricted stock unit award (\"RSU\") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award."}],"balance_after":380675,"source":{"system":"sec-edgar","filing":"0001209191-24-000930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124000930/doc4.xml","form_type":"4"}},{"id":1686949,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-01-05T02:36:41.000Z","date":"2024-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":16533,"price":17.4,"value":287674.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock units."}],"balance_after":310675,"source":{"system":"sec-edgar","filing":"0001209191-24-000930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124000930/doc4.xml","form_type":"4"}},{"id":1686948,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-01-05T02:36:41.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":28334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2022, 33.33% of which vested on January 3, 2024 upon the achievement of a non-financial performance goal."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 11,111 shares acquired on May 19, 2023 pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":327208,"source":{"system":"sec-edgar","filing":"0001209191-24-000930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124000930/doc4.xml","form_type":"4"}},{"id":1917846,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-18T23:08:26.000Z","date":"2023-04-17","kind":"exercise","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to the option vested on the grant date and one-third of the shares subject to the option vested on each one year anniversary of the grant date of August 31, 2018."}],"balance_after":0,"derivative":{"exercise_price":13.07,"exercise_date":"2018-08-31","expiration_date":"2018-08-31","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-23-024723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123024723/doc4.xml","form_type":"4"}},{"id":1917845,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-18T23:08:26.000Z","date":"2023-04-17","kind":"sale","planned":false,"acquired":false,"shares":12500,"price":20,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":287763,"source":{"system":"sec-edgar","filing":"0001209191-23-024723","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123024723/doc4.xml","form_type":"4"}},{"id":1917844,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-18T23:08:26.000Z","date":"2023-04-17","kind":"exercise","planned":false,"acquired":true,"shares":12500,"price":13.07,"value":163375.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":300263,"source":{"system":"sec-edgar","filing":"0001209191-23-024723","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123024723/doc4.xml","form_type":"4"}},{"id":1931867,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-03T23:22:47.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":1000,"derivative":{"exercise_price":6.47,"exercise_date":"2020-10-31","expiration_date":"2029-10-31","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-23-022396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022396/doc4.xml","form_type":"4"}},{"id":1931866,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-03T23:22:47.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":7.69,"exercise_date":"2020-07-31","expiration_date":"2029-07-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-022396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022396/doc4.xml","form_type":"4"}},{"id":1931865,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-03T23:22:47.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":false,"shares":23100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":8.52,"exercise_date":"2020-01-15","expiration_date":"2029-01-15","underlying":"Common Stock","underlying_shares":23100},"source":{"system":"sec-edgar","filing":"0001209191-23-022396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022396/doc4.xml","form_type":"4"}},{"id":1931864,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-03T23:22:47.000Z","date":"2023-03-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":30799,"price":17.57,"value":541138.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock units."}],"balance_after":287763,"source":{"system":"sec-edgar","filing":"0001209191-23-022396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022396/doc4.xml","form_type":"4"}},{"id":1931863,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-03T23:22:47.000Z","date":"2023-03-30","kind":"grant","planned":false,"acquired":true,"shares":56667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2022, 66.67% of which vested on April 3, 2023 upon the achievement of two non-financial performance goals."}],"balance_after":318562,"source":{"system":"sec-edgar","filing":"0001209191-23-022396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022396/doc4.xml","form_type":"4"}},{"id":1931862,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-03T23:22:47.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":false,"shares":36100,"price":17.0091,"value":614028.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":261895,"source":{"system":"sec-edgar","filing":"0001209191-23-022396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022396/doc4.xml","form_type":"4"}},{"id":1931861,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-03T23:22:47.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":6.47,"value":19410.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":297995,"source":{"system":"sec-edgar","filing":"0001209191-23-022396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022396/doc4.xml","form_type":"4"}},{"id":1931860,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-03T23:22:47.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":7.69,"value":76900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":294995,"source":{"system":"sec-edgar","filing":"0001209191-23-022396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022396/doc4.xml","form_type":"4"}},{"id":1931859,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-03T23:22:47.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":true,"shares":23100,"price":8.52,"value":196812.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":284995,"source":{"system":"sec-edgar","filing":"0001209191-23-022396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022396/doc4.xml","form_type":"4"}},{"id":1934741,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-29","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":9.13,"exercise_date":"2016-05-21","expiration_date":"2025-05-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934740,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":4.37,"exercise_date":"2019-03-30","expiration_date":"2028-03-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934739,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":false,"shares":24500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":4.65,"exercise_date":"2019-01-19","expiration_date":"2028-01-19","underlying":"Common Stock","underlying_shares":24500},"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934738,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":1.04,"exercise_date":"2018-08-31","expiration_date":"2027-08-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934737,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":1.08,"exercise_date":"2018-06-30","expiration_date":"2027-06-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934736,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":false,"shares":53054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"23,054 shares vested on the grant date of 01/05/2017 and 25% of the remaining 30,000 shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":1.23,"exercise_date":"2017-01-05","expiration_date":"2027-01-05","underlying":"Common Stock","underlying_shares":53054},"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934735,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":1.26,"exercise_date":"2017-06-30","expiration_date":"2026-06-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934734,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":false,"shares":4873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vested on the grant date."}],"balance_after":0,"derivative":{"exercise_price":1.88,"exercise_date":"2016-03-14","expiration_date":"2026-03-14","underlying":"Common Stock","underlying_shares":4873},"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934733,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":2.15,"exercise_date":"2017-03-04","expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934732,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-29","kind":"sale","planned":false,"acquired":false,"shares":41242,"price":16,"value":659872.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":261895,"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934731,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-29","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":9.13,"value":136950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":303137,"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934730,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-28","kind":"sale","planned":false,"acquired":false,"shares":196563,"price":15,"value":2948445.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":288137,"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934729,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":true,"shares":30000,"price":4.37,"value":131100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":484700,"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934728,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":true,"shares":24500,"price":4.65,"value":113925.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":454700,"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934727,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":1.04,"value":10400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":430200,"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934726,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":1.08,"value":16200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":420200,"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934725,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":true,"shares":53054,"price":1.23,"value":65256.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":405200,"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934724,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":1.26,"value":18900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":352146,"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934723,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":true,"shares":4873,"price":1.88,"value":9161.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":337146,"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":1934722,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-03-31T01:04:35.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":2.15,"value":32250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":332273,"source":{"system":"sec-edgar","filing":"0001209191-23-021743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123021743/doc4.xml","form_type":"4"}},{"id":2053523,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-01-18T00:39:46.000Z","date":"2023-01-15","kind":"tax_withholding","acquired":false,"shares":1079,"price":8.95,"value":9657.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units."}],"balance_after":317273,"source":{"system":"sec-edgar","filing":"0001209191-23-003606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123003606/doc4.xml","form_type":"4"}},{"id":2065705,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T23:24:48.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":204000,"derivative":{"exercise_price":8.52,"exercise_date":"2024-01-03","expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001209191-23-001342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123001342/doc4.xml","form_type":"4"}},{"id":2065704,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-01-04T23:24:48.000Z","date":"2023-01-04","kind":"tax_withholding","acquired":false,"shares":13994,"price":8.42,"value":117829.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units."}],"balance_after":318352,"source":{"system":"sec-edgar","filing":"0001209191-23-001342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123001342/doc4.xml","form_type":"4"}},{"id":2065703,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-01-04T23:24:48.000Z","date":"2023-01-03","kind":"tax_withholding","acquired":false,"shares":18854,"price":8.52,"value":160636.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units."}],"balance_after":332346,"source":{"system":"sec-edgar","filing":"0001209191-23-001342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123001342/doc4.xml","form_type":"4"}},{"id":2065702,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-01-04T23:24:48.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":90667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents a restricted stock unit award (\"RSU\") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award."}],"balance_after":351200,"source":{"system":"sec-edgar","filing":"0001209191-23-001342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123001342/doc4.xml","form_type":"4"}},{"id":2065701,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-01-04T23:24:48.000Z","date":"2022-12-30","kind":"tax_withholding","acquired":false,"shares":12773,"price":9.4,"value":120066.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock units."}],"balance_after":260533,"source":{"system":"sec-edgar","filing":"0001209191-23-001342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123001342/doc4.xml","form_type":"4"}},{"id":2065700,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-01-04T23:24:48.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2019, 66.67% of which vested on December 30, 2022 upon the achievement of two non-financial performance goals and a performance restricted stock unit award that was granted on January 4, 2021, 33.33% of which vested on December 30, 2022 upon the achievement of a non-financial performance goal."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,545 shares acquired on May 20, 2022 and 6,566 shares acquired on November 18, 2022 pursuant to the Issuer's 2014 Employee Stock Purchase Plan"}],"balance_after":273306,"source":{"system":"sec-edgar","filing":"0001209191-23-001342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123001342/doc4.xml","form_type":"4"}},{"id":2400933,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2022-02-11T23:34:39.000Z","date":"2022-01-15","kind":"tax_withholding","acquired":false,"shares":827,"price":4.24,"value":3506.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units."}],"balance_after":238695,"source":{"system":"sec-edgar","filing":"0001209191-22-008999","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919122008999/doc4.xml","form_type":"4"}},{"id":2442777,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-06T00:12:51.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":174000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":174000,"derivative":{"exercise_price":4.88,"exercise_date":"2023-01-03","expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":174000},"source":{"system":"sec-edgar","filing":"0001209191-22-001987","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919122001987/doc4.xml","form_type":"4"}},{"id":2442776,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2022-01-06T00:12:51.000Z","date":"2022-01-04","kind":"tax_withholding","acquired":false,"shares":11845,"price":4.62,"value":54723.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units."}],"balance_after":239522,"source":{"system":"sec-edgar","filing":"0001209191-22-001987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919122001987/doc4.xml","form_type":"4"}},{"id":2442775,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2022-01-06T00:12:51.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":77333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a restricted stock unit award (\"RSU\") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award."}],"balance_after":251367,"source":{"system":"sec-edgar","filing":"0001209191-22-001987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919122001987/doc4.xml","form_type":"4"}},{"id":2442774,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2022-01-06T00:12:51.000Z","date":"2022-01-03","kind":"tax_withholding","acquired":false,"shares":3919,"price":4.88,"value":19124.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 418 shares acquired on November 19, 2021 pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":174034,"source":{"system":"sec-edgar","filing":"0001209191-22-001987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919122001987/doc4.xml","form_type":"4"}},{"id":2555645,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2021-09-30T21:45:39.000Z","date":"2021-09-28","kind":"tax_withholding","acquired":false,"shares":2839,"price":6.5,"value":18453.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to a performance restricted stock unit award."}],"balance_after":177535,"source":{"system":"sec-edgar","filing":"0001209191-21-058249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919121058249/doc4.xml","form_type":"4"}},{"id":2555644,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2021-09-30T21:45:39.000Z","date":"2021-09-28","kind":"grant","acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2020, 33.33% of which vested on September 28, 2021 upon the achievement of a non-financial performance goal."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,755 shares acquired on May 20, 2021 pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":180374,"source":{"system":"sec-edgar","filing":"0001209191-21-058249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919121058249/doc4.xml","form_type":"4"}},{"id":2903902,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2021-01-19T23:23:59.000Z","date":"2021-01-19","kind":"tax_withholding","acquired":false,"shares":994,"price":6.68,"value":6639.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted\nstock units."}],"balance_after":169952,"source":{"system":"sec-edgar","filing":"0001209191-21-004098","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919121004098/doc4.xml","form_type":"4"}},{"id":2903901,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2021-01-19T23:23:59.000Z","date":"2021-01-15","kind":"tax_withholding","acquired":false,"shares":686,"price":6.48,"value":4445.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted\nstock units."}],"balance_after":170946,"source":{"system":"sec-edgar","filing":"0001209191-21-004098","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919121004098/doc4.xml","form_type":"4"}},{"id":2914611,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-06T21:26:36.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":90000,"derivative":{"exercise_price":5.8,"exercise_date":"2022-01-04","expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-21-002074","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919121002074/doc4.xml","form_type":"4"}},{"id":2914610,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2021-01-06T21:26:36.000Z","date":"2021-01-04","kind":"tax_withholding","acquired":false,"shares":2773,"price":5.8,"value":16083.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon\nthe vesting of certain shares of common stock subject to a performance restricted stock unit award."}],"balance_after":171632,"source":{"system":"sec-edgar","filing":"0001209191-21-002074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919121002074/doc4.xml","form_type":"4"}},{"id":2914609,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2021-01-06T21:26:36.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":6750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 15, 2019, 33.33% of which vested\non January 4, 2021 upon the achievement of a non-financial performance goal."}],"balance_after":174405,"source":{"system":"sec-edgar","filing":"0001209191-21-002074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919121002074/doc4.xml","form_type":"4"}},{"id":2914608,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27972,"kind":"person","name":"Mancini Marianna","position":1,"cik":"0001838112","reported_name":"Mancini Marianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2021-01-06T21:26:36.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":73000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award (\"RSU\") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject\nto the RSU shall vest on each one year anniversary of the grant date of the award."}],"balance_after":167655,"source":{"system":"sec-edgar","filing":"0001209191-21-002074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919121002074/doc4.xml","form_type":"4"}}]}